AHI Commends FDA Action to Protect Pet Health

The Animal Health Institute (AHI) commends the Food and Drug Administration (FDA) for protecting the health of pets through their recent efforts to enforce laws governing animal medicines.  The FDA issued warning letters to six sellers of unapproved animal drugs being illegally marketed with claims to treat seizures.

We urge pet owners and veterinarians alike to be vigilant and aware of the regulatory status of drugs being given to animals.  The FDA approves pioneer and generic drugs that are proven to be safe for the animal, effective at treating the listed medical condition of the animal and manufactured to ensure safety.  FDA-approved animal drug labels will say “Approved by FDA under NADA # XXX-XXX” or “Approved by FDA under ANADA # XXX-XXX.” This helps users to clearly identify FDA-approved animal drugs and distinguish them from unapproved ones.

Any medications not carrying that number have not been approved by the FDA and are not guaranteed to be safe and effective.   Veterinarians and pet owners should always be aware of whether the drug being administered is FDA-approved and the increased risks associated with unapproved drugs.

The FDA’s ability and commitment to enforcing these standards is essential to advancing the science of animal health while protecting consumers, animals, and the integrity of the industry.  Congress plays an important role by ensuring the agency has the resources for these enforcement activities.  We applaud these efforts and continue to support policies that prioritize animal health and well-being.

Read more about the FDA’s actions here: FDA Update